

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | maintenance of gastrointestinal epithelium (GO:0030277) | 9.00775744 |
| 2 | positive regulation of respiratory burst (GO:0060267) | 8.11221362 |
| 3 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 7.96490159 |
| 4 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 7.57916847 |
| 5 | hemidesmosome assembly (GO:0031581) | 7.16553077 |
| 6 | epithelial structure maintenance (GO:0010669) | 6.88960445 |
| 7 | intestinal epithelial cell development (GO:0060576) | 6.53233121 |
| 8 | cellular glucuronidation (GO:0052695) | 6.17985623 |
| 9 | uronic acid metabolic process (GO:0006063) | 5.92265529 |
| 10 | glucuronate metabolic process (GO:0019585) | 5.92265529 |
| 11 | glomerular filtration (GO:0003094) | 5.88674919 |
| 12 | O-glycan processing (GO:0016266) | 5.88421982 |
| 13 | renal system process involved in regulation of blood volume (GO:0001977) | 5.38184786 |
| 14 | renal filtration (GO:0097205) | 5.36098237 |
| 15 | actin filament depolymerization (GO:0030042) | 5.34521594 |
| 16 | L-fucose catabolic process (GO:0042355) | 5.34461066 |
| 17 | fucose catabolic process (GO:0019317) | 5.34461066 |
| 18 | L-fucose metabolic process (GO:0042354) | 5.34461066 |
| 19 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 5.13124453 |
| 20 | hepatocyte apoptotic process (GO:0097284) | 5.10358812 |
| 21 | intestinal absorption (GO:0050892) | 5.09686092 |
| 22 | cGMP-mediated signaling (GO:0019934) | 5.08294654 |
| 23 | ethanol oxidation (GO:0006069) | 4.96286497 |
| 24 | glucocorticoid biosynthetic process (GO:0006704) | 4.82484380 |
| 25 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.80459894 |
| 26 | bile acid and bile salt transport (GO:0015721) | 4.68576378 |
| 27 | prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:006052 | 4.59700512 |
| 28 | regulation of respiratory burst (GO:0060263) | 4.59134300 |
| 29 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.58985925 |
| 30 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.58985925 |
| 31 | negative regulation of myotube differentiation (GO:0010832) | 4.54361917 |
| 32 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.48660587 |
| 33 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.47277857 |
| 34 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.47277857 |
| 35 | endocrine process (GO:0050886) | 4.47277857 |
| 36 | regulation of vitamin metabolic process (GO:0030656) | 4.38631580 |
| 37 | sulfate transmembrane transport (GO:1902358) | 4.38574119 |
| 38 | regulation of viral release from host cell (GO:1902186) | 4.38018763 |
| 39 | regulation of pseudopodium assembly (GO:0031272) | 4.37887709 |
| 40 | desmosome organization (GO:0002934) | 4.30482751 |
| 41 | sulfation (GO:0051923) | 4.28566055 |
| 42 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.23081622 |
| 43 | vitamin transmembrane transport (GO:0035461) | 4.15608963 |
| 44 | regulation of intracellular pH (GO:0051453) | 4.15447601 |
| 45 | digestive system process (GO:0022600) | 4.13928722 |
| 46 | flavonoid metabolic process (GO:0009812) | 4.13460133 |
| 47 | thyroid hormone metabolic process (GO:0042403) | 4.10601515 |
| 48 | cellular response to pH (GO:0071467) | 4.09613310 |
| 49 | regulation of T cell tolerance induction (GO:0002664) | 4.09305198 |
| 50 | nucleotide-sugar biosynthetic process (GO:0009226) | 4.07259603 |
| 51 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.05814703 |
| 52 | protein autoprocessing (GO:0016540) | 4.05446353 |
| 53 | regulation of RIG-I signaling pathway (GO:0039535) | 4.03480168 |
| 54 | antimicrobial humoral response (GO:0019730) | 3.98749411 |
| 55 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.98432551 |
| 56 | antibacterial humoral response (GO:0019731) | 3.98230991 |
| 57 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.96869821 |
| 58 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.96294316 |
| 59 | positive regulation of fatty acid oxidation (GO:0046321) | 3.95440712 |
| 60 | regulation of cGMP biosynthetic process (GO:0030826) | 3.95238589 |
| 61 | ethanol metabolic process (GO:0006067) | 3.89673811 |
| 62 | regulation of cellular extravasation (GO:0002691) | 3.89498583 |
| 63 | labyrinthine layer development (GO:0060711) | 3.88892499 |
| 64 | one-carbon metabolic process (GO:0006730) | 3.88373831 |
| 65 | regulation of systemic arterial blood pressure (GO:0003073) | 3.82876578 |
| 66 | regulation of cellular pH (GO:0030641) | 3.80533006 |
| 67 | regulation of cell-cell adhesion mediated by cadherin (GO:2000047) | 3.79699829 |
| 68 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.76852714 |
| 69 | branching involved in prostate gland morphogenesis (GO:0060442) | 3.76542112 |
| 70 | sulfur amino acid catabolic process (GO:0000098) | 3.75337615 |
| 71 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72794589 |
| 72 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.70673911 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 3.70102985 |
| 74 | lipopolysaccharide biosynthetic process (GO:0009103) | 3.68374154 |
| 75 | protein O-linked glycosylation (GO:0006493) | 3.66963224 |
| 76 | fucose metabolic process (GO:0006004) | 3.66722841 |
| 77 | positive regulation of actin filament depolymerization (GO:0030836) | 3.65817653 |
| 78 | transcytosis (GO:0045056) | 3.64938054 |
| 79 | nucleotide-sugar metabolic process (GO:0009225) | 3.60104503 |
| 80 | galactose catabolic process (GO:0019388) | 3.56769396 |
| 81 | negative regulation of protein tyrosine kinase activity (GO:0061099) | 3.53282381 |
| 82 | sulfate transport (GO:0008272) | 3.50585827 |
| 83 | regulation of chemokine secretion (GO:0090196) | 3.50278142 |
| 84 | lung secretory cell differentiation (GO:0061140) | 3.49065101 |
| 85 | response to acidic pH (GO:0010447) | 3.47371667 |
| 86 | cell differentiation involved in embryonic placenta development (GO:0060706) | 3.46127575 |
| 87 | fucosylation (GO:0036065) | 3.44871576 |
| 88 | angiotensin maturation (GO:0002003) | 3.43940501 |
| 89 | cell communication involved in cardiac conduction (GO:0086065) | 3.43801014 |
| 90 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.41958038 |
| 91 | NADH metabolic process (GO:0006734) | 3.39792147 |
| 92 | regulation of viral entry into host cell (GO:0046596) | 3.36768145 |
| 93 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.34282993 |
| 94 | regulation of pH (GO:0006885) | 3.33161079 |
| 95 | thrombin receptor signaling pathway (GO:0070493) | 3.32721913 |
| 96 | positive regulation of tolerance induction (GO:0002645) | 3.31862610 |
| 97 | eosinophil chemotaxis (GO:0048245) | 3.31080841 |
| 98 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.29953737 |
| 99 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.28410526 |
| 100 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.26323405 |
| 101 | drug transmembrane transport (GO:0006855) | 3.25851516 |
| 102 | striated muscle atrophy (GO:0014891) | 3.25776614 |
| 103 | intestinal cholesterol absorption (GO:0030299) | 3.25629299 |
| 104 | sodium ion homeostasis (GO:0055078) | 3.25074912 |
| 105 | epithelial cell-cell adhesion (GO:0090136) | 3.24403319 |
| 106 | epoxygenase P450 pathway (GO:0019373) | 3.22704019 |
| 107 | regulation of cGMP metabolic process (GO:0030823) | 3.21321186 |
| 108 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.19561105 |
| 109 | vitamin A metabolic process (GO:0006776) | 3.19426509 |
| 110 | regulation of guanylate cyclase activity (GO:0031282) | 3.18417412 |
| 111 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.17580183 |
| 112 | cardiac conduction (GO:0061337) | 3.10329172 |
| 113 | GDP-mannose metabolic process (GO:0019673) | 3.08692609 |
| 114 | diol metabolic process (GO:0034311) | 3.08311101 |
| 115 | sulfur compound transport (GO:0072348) | 3.08206012 |
| 116 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.08059819 |
| 117 | neurotransmitter biosynthetic process (GO:0042136) | 3.07963111 |
| 118 | lipopolysaccharide metabolic process (GO:0008653) | 3.07533586 |
| 119 | monovalent inorganic cation homeostasis (GO:0055067) | 3.07409480 |
| 120 | excretion (GO:0007588) | 3.07163292 |
| 121 | hydrogen peroxide catabolic process (GO:0042744) | 3.05783116 |
| 122 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.03039137 |
| 123 | drug transport (GO:0015893) | 3.01497872 |
| 124 | auditory receptor cell differentiation (GO:0042491) | 3.01072964 |
| 125 | cellular monovalent inorganic cation homeostasis (GO:0030004) | 3.00140718 |
| 126 | thyroid hormone generation (GO:0006590) | 2.99213551 |
| 127 | glycosylceramide metabolic process (GO:0006677) | 2.99204802 |
| 128 | receptor recycling (GO:0001881) | 2.97987201 |
| 129 | diterpenoid biosynthetic process (GO:0016102) | 2.97971662 |
| 130 | phospholipid translocation (GO:0045332) | 2.97942823 |
| 131 | lipid translocation (GO:0034204) | 2.97942823 |
| 132 | cellular ketone body metabolic process (GO:0046950) | 2.97190821 |
| 133 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.95953991 |
| 134 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.95857855 |
| 135 | response to hepatocyte growth factor (GO:0035728) | 2.95857855 |
| 136 | eosinophil migration (GO:0072677) | 2.93802056 |
| 137 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.93174168 |
| 138 | positive regulation of pseudopodium assembly (GO:0031274) | 2.92569274 |
| 139 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.92401262 |
| 140 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.90976477 |
| 141 | sperm capacitation (GO:0048240) | 2.90843269 |
| 142 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.90809898 |
| 143 | oligosaccharide biosynthetic process (GO:0009312) | 2.90338006 |
| 144 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.90116477 |
| 145 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.88944303 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 2.88751173 |
| 147 | tight junction assembly (GO:0070830) | 2.86735247 |
| 148 | phosphatidylcholine biosynthetic process (GO:0006656) | 2.86716292 |
| 149 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.86646695 |
| 150 | bicarbonate transport (GO:0015701) | 2.85532608 |
| 151 | urea cycle (GO:0000050) | 2.85326592 |
| 152 | regulation of protein glycosylation (GO:0060049) | 2.84922887 |
| 153 | phosphatidylserine metabolic process (GO:0006658) | 2.84705579 |
| 154 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.84548003 |
| 155 | drug catabolic process (GO:0042737) | 2.83862922 |
| 156 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 2.81792515 |
| 157 | skeletal muscle adaptation (GO:0043501) | 2.81438624 |
| 158 | glandular epithelial cell differentiation (GO:0002067) | 2.81027140 |
| 159 | hexose catabolic process (GO:0019320) | 2.80494495 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.49382795 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.27975082 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.79120445 |
| 4 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.19515620 |
| 5 | SOX2_20726797_ChIP-Seq_SW620_Human | 3.13660986 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.09056820 |
| 7 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.96871030 |
| 8 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.82938479 |
| 9 | GATA6_25053715_ChIP-Seq_YYC3_Human | 2.79641841 |
| 10 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.49976617 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.48715990 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.42309374 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.14087190 |
| 14 | KLF5_25053715_ChIP-Seq_YYC3_Human | 2.10315367 |
| 15 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.08419205 |
| 16 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 2.07835726 |
| 17 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.07452547 |
| 18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.02655440 |
| 19 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.98044904 |
| 20 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.97617740 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97336109 |
| 22 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.93121566 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.89447626 |
| 24 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.89080260 |
| 25 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.89061082 |
| 26 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.88498090 |
| 27 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.85260536 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.83371394 |
| 29 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81353026 |
| 30 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.80919367 |
| 31 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75676677 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.71110803 |
| 33 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.70157022 |
| 34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.66990378 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.63423972 |
| 36 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.61003300 |
| 37 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60834612 |
| 38 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.60479763 |
| 39 | VDR_22108803_ChIP-Seq_LS180_Human | 1.57392087 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.52987373 |
| 41 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.52936276 |
| 42 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.52371300 |
| 43 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.51776304 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50975794 |
| 45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.50082391 |
| 46 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.49827490 |
| 47 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.49149065 |
| 48 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.49085292 |
| 49 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.49085292 |
| 50 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.43459407 |
| 51 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.43214811 |
| 52 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.40468814 |
| 53 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38327851 |
| 54 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.35437317 |
| 55 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.35138498 |
| 56 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.34934060 |
| 57 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34471242 |
| 58 | ATF3_27146783_Chip-Seq_COLON_Human | 1.34132891 |
| 59 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.31715054 |
| 60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.29329309 |
| 61 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.28666445 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.27759967 |
| 63 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.25714066 |
| 64 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25683796 |
| 65 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.25334618 |
| 66 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22043064 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.21404286 |
| 68 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17694568 |
| 69 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.11931753 |
| 70 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.11566891 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.10198214 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09604143 |
| 73 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07026886 |
| 74 | GATA1_19941826_ChIP-Seq_K562_Human | 1.06955996 |
| 75 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.06839143 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05486740 |
| 77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04758575 |
| 78 | GATA2_19941826_ChIP-Seq_K562_Human | 1.04266888 |
| 79 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.03824727 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.03565839 |
| 81 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.02576902 |
| 82 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.01794534 |
| 83 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.00128104 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00027580 |
| 85 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99862588 |
| 86 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.99186216 |
| 87 | SA1_27219007_Chip-Seq_Bcells_Human | 0.98227859 |
| 88 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.97190257 |
| 89 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97161064 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.96303206 |
| 91 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94212754 |
| 92 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.91930636 |
| 93 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91698565 |
| 94 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.91633730 |
| 95 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.91518455 |
| 96 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.90590064 |
| 97 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90043165 |
| 98 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89869281 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.89049926 |
| 100 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88294497 |
| 101 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87636579 |
| 102 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.87545788 |
| 103 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.86762867 |
| 104 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86622243 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.86158599 |
| 106 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.85875922 |
| 107 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.85163473 |
| 108 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.84929428 |
| 109 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.84219592 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83867521 |
| 111 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.82909544 |
| 112 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.82228024 |
| 113 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.82142017 |
| 114 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81157183 |
| 115 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.80612897 |
| 116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.80443554 |
| 117 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.78495152 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.78292511 |
| 119 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77938835 |
| 120 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.77484399 |
| 121 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.77001929 |
| 122 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.76349034 |
| 123 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75399685 |
| 124 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.75170378 |
| 125 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.74831385 |
| 126 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.74683201 |
| 127 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72946149 |
| 128 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.72943134 |
| 129 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.72863200 |
| 130 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.72646695 |
| 131 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72590000 |
| 132 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.71892125 |
| 133 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.71267526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 7.94804220 |
| 2 | MP0004264_abnormal_extraembryonic_tissu | 4.76639304 |
| 3 | MP0003866_abnormal_defecation | 4.14292136 |
| 4 | MP0000462_abnormal_digestive_system | 3.97391789 |
| 5 | MP0001666_abnormal_nutrient_absorption | 3.31253603 |
| 6 | MP0000537_abnormal_urethra_morphology | 3.24423530 |
| 7 | MP0010155_abnormal_intestine_physiology | 2.97560541 |
| 8 | MP0002822_catalepsy | 2.87336406 |
| 9 | MP0001663_abnormal_digestive_system | 2.86404603 |
| 10 | MP0005381_digestive/alimentary_phenotyp | 2.80120570 |
| 11 | MP0001873_stomach_inflammation | 2.70996544 |
| 12 | MP0003283_abnormal_digestive_organ | 2.68026758 |
| 13 | MP0005360_urolithiasis | 2.61967241 |
| 14 | MP0000490_abnormal_crypts_of | 2.47731891 |
| 15 | MP0002138_abnormal_hepatobiliary_system | 2.46421180 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.42772620 |
| 17 | MP0000477_abnormal_intestine_morphology | 2.29768358 |
| 18 | MP0001664_abnormal_digestion | 2.28740478 |
| 19 | MP0003705_abnormal_hypodermis_morpholog | 2.28516276 |
| 20 | MP0010352_gastrointestinal_tract_polyps | 2.27244037 |
| 21 | MP0001849_ear_inflammation | 2.25482152 |
| 22 | MP0006054_spinal_hemorrhage | 2.25479762 |
| 23 | MP0005167_abnormal_blood-brain_barrier | 2.16054319 |
| 24 | MP0010678_abnormal_skin_adnexa | 2.05546987 |
| 25 | MP0005377_hearing/vestibular/ear_phenot | 1.91886441 |
| 26 | MP0003878_abnormal_ear_physiology | 1.91886441 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.90496684 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 1.89334699 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.84254602 |
| 30 | MP0000538_abnormal_urinary_bladder | 1.77743975 |
| 31 | MP0001765_abnormal_ion_homeostasis | 1.70211231 |
| 32 | MP0002876_abnormal_thyroid_physiology | 1.67867201 |
| 33 | MP0002796_impaired_skin_barrier | 1.65417597 |
| 34 | MP0005409_darkened_coat_color | 1.54731411 |
| 35 | MP0002009_preneoplasia | 1.53791776 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.50973227 |
| 37 | MP0003724_increased_susceptibility_to | 1.50962138 |
| 38 | MP0008004_abnormal_stomach_pH | 1.50222537 |
| 39 | MP0005670_abnormal_white_adipose | 1.48514921 |
| 40 | MP0004947_skin_inflammation | 1.44073285 |
| 41 | MP0000678_abnormal_parathyroid_gland | 1.43062351 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.42100204 |
| 43 | MP0003252_abnormal_bile_duct | 1.36706842 |
| 44 | MP0005365_abnormal_bile_salt | 1.34336837 |
| 45 | MP0003868_abnormal_feces_composition | 1.33714650 |
| 46 | MP0005451_abnormal_body_composition | 1.32447685 |
| 47 | MP0002139_abnormal_hepatobiliary_system | 1.31251805 |
| 48 | MP0005187_abnormal_penis_morphology | 1.30223864 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.27925556 |
| 50 | MP0002060_abnormal_skin_morphology | 1.23600581 |
| 51 | MP0000230_abnormal_systemic_arterial | 1.23406452 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.22088963 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.21458426 |
| 54 | MP0005166_decreased_susceptibility_to | 1.21092408 |
| 55 | MP0001216_abnormal_epidermal_layer | 1.19466202 |
| 56 | MP0005310_abnormal_salivary_gland | 1.18581078 |
| 57 | MP0002234_abnormal_pharynx_morphology | 1.17743449 |
| 58 | MP0003879_abnormal_hair_cell | 1.15960318 |
| 59 | MP0000470_abnormal_stomach_morphology | 1.15060877 |
| 60 | MP0005501_abnormal_skin_physiology | 1.14927596 |
| 61 | MP0003303_peritoneal_inflammation | 1.14250466 |
| 62 | MP0003693_abnormal_embryo_hatching | 1.13658101 |
| 63 | MP0005636_abnormal_mineral_homeostasis | 1.13579022 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.11567994 |
| 65 | MP0002098_abnormal_vibrissa_morphology | 1.11059085 |
| 66 | MP0008872_abnormal_physiological_respon | 1.10541519 |
| 67 | MP0001188_hyperpigmentation | 1.06128001 |
| 68 | MP0009053_abnormal_anal_canal | 1.06018822 |
| 69 | MP0009643_abnormal_urine_homeostasis | 1.05065685 |
| 70 | MP0004782_abnormal_surfactant_physiolog | 1.03577587 |
| 71 | MP0000467_abnormal_esophagus_morphology | 1.02964416 |
| 72 | MP0004043_abnormal_pH_regulation | 1.02663162 |
| 73 | MP0004019_abnormal_vitamin_homeostasis | 0.95959253 |
| 74 | MP0009840_abnormal_foam_cell | 0.93958212 |
| 75 | MP0010329_abnormal_lipoprotein_level | 0.93748870 |
| 76 | MP0004147_increased_porphyrin_level | 0.92839209 |
| 77 | MP0009384_cardiac_valve_regurgitation | 0.89939979 |
| 78 | MP0005257_abnormal_intraocular_pressure | 0.89781047 |
| 79 | MP0009785_altered_susceptibility_to | 0.87989070 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.87628842 |
| 81 | MP0003566_abnormal_cell_adhesion | 0.86563380 |
| 82 | MP0006082_CNS_inflammation | 0.85840463 |
| 83 | MP0004484_altered_response_of | 0.85018405 |
| 84 | MP0010771_integument_phenotype | 0.83486783 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 0.82628309 |
| 86 | MP0003045_fibrosis | 0.82193953 |
| 87 | MP0005367_renal/urinary_system_phenotyp | 0.82015011 |
| 88 | MP0000516_abnormal_urinary_system | 0.82015011 |
| 89 | MP0004858_abnormal_nervous_system | 0.81339325 |
| 90 | MP0003075_altered_response_to | 0.79741707 |
| 91 | MP0005058_abnormal_lysosome_morphology | 0.79135264 |
| 92 | MP0002118_abnormal_lipid_homeostasis | 0.77784472 |
| 93 | MP0000383_abnormal_hair_follicle | 0.74578625 |
| 94 | MP0000377_abnormal_hair_follicle | 0.74213095 |
| 95 | MP0005275_abnormal_skin_tensile | 0.73441466 |
| 96 | MP0000762_abnormal_tongue_morphology | 0.73209016 |
| 97 | MP0005666_abnormal_adipose_tissue | 0.72924457 |
| 98 | MP0000465_gastrointestinal_hemorrhage | 0.72448072 |
| 99 | MP0002136_abnormal_kidney_physiology | 0.72002288 |
| 100 | MP0005332_abnormal_amino_acid | 0.70014325 |
| 101 | MP0000604_amyloidosis | 0.68209808 |
| 102 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.67726075 |
| 103 | MP0004272_abnormal_basement_membrane | 0.66917953 |
| 104 | MP0001764_abnormal_homeostasis | 0.66128267 |
| 105 | MP0002132_abnormal_respiratory_system | 0.63289473 |
| 106 | MP0001845_abnormal_inflammatory_respons | 0.63040118 |
| 107 | MP0003329_amyloid_beta_deposits | 0.62268804 |
| 108 | MP0005319_abnormal_enzyme/_coenzyme | 0.60833234 |
| 109 | MP0002896_abnormal_bone_mineralization | 0.60298645 |
| 110 | MP0005023_abnormal_wound_healing | 0.59356385 |
| 111 | MP0001727_abnormal_embryo_implantation | 0.59220759 |
| 112 | MP0000566_synostosis | 0.58404596 |
| 113 | MP0009333_abnormal_splenocyte_physiolog | 0.57174222 |
| 114 | MP0001485_abnormal_pinna_reflex | 0.57112050 |
| 115 | MP0008873_increased_physiological_sensi | 0.56715787 |
| 116 | MP0002971_abnormal_brown_adipose | 0.56587869 |
| 117 | MP0005025_abnormal_response_to | 0.56478413 |
| 118 | MP0004185_abnormal_adipocyte_glucose | 0.55363255 |
| 119 | MP0000609_abnormal_liver_physiology | 0.55041793 |
| 120 | MP0002006_tumorigenesis | 0.54764874 |
| 121 | MP0003941_abnormal_skin_development | 0.54346918 |
| 122 | MP0000613_abnormal_salivary_gland | 0.54111549 |
| 123 | MP0005248_abnormal_Harderian_gland | 0.53256984 |
| 124 | MP0005165_increased_susceptibility_to | 0.53192768 |
| 125 | MP0002148_abnormal_hypersensitivity_rea | 0.52848241 |
| 126 | MP0001756_abnormal_urination | 0.52633481 |
| 127 | MP0001501_abnormal_sleep_pattern | 0.51845264 |
| 128 | MP0001790_abnormal_immune_system | 0.51252601 |
| 129 | MP0005387_immune_system_phenotype | 0.51252601 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Right ventricular cardiomyopathy (HP:0011663) | 7.59651402 |
| 2 | Ileus (HP:0002595) | 6.62971841 |
| 3 | Onycholysis (HP:0001806) | 6.30125401 |
| 4 | Milia (HP:0001056) | 5.51657606 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.30174977 |
| 6 | Fragile nails (HP:0001808) | 5.27648349 |
| 7 | Atrophic scars (HP:0001075) | 5.07168742 |
| 8 | Abnormality of the 1st metacarpal (HP:0010009) | 4.80710624 |
| 9 | Flat acetabular roof (HP:0003180) | 4.60964431 |
| 10 | Hyponatremia (HP:0002902) | 4.58435553 |
| 11 | Pustule (HP:0200039) | 4.33933153 |
| 12 | Abdominal distention (HP:0003270) | 4.16190587 |
| 13 | Hypokalemia (HP:0002900) | 4.08663758 |
| 14 | Abnormal tarsal ossification (HP:0008369) | 4.08420548 |
| 15 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 4.07348209 |
| 16 | Metabolic alkalosis (HP:0200114) | 3.98756685 |
| 17 | Ureteral stenosis (HP:0000071) | 3.88805153 |
| 18 | Abnormality of potassium homeostasis (HP:0011042) | 3.74497281 |
| 19 | Flat capital femoral epiphysis (HP:0003370) | 3.62443201 |
| 20 | Plantar hyperkeratosis (HP:0007556) | 3.59219773 |
| 21 | Ureteral obstruction (HP:0006000) | 3.58075553 |
| 22 | Micronodular cirrhosis (HP:0001413) | 3.56472843 |
| 23 | Abnormality of chloride homeostasis (HP:0011422) | 3.53811015 |
| 24 | Abnormality of sodium homeostasis (HP:0010931) | 3.44589770 |
| 25 | Pili torti (HP:0003777) | 3.42877605 |
| 26 | Abnormality of carpal bone ossification (HP:0006257) | 3.38873515 |
| 27 | Villous atrophy (HP:0011473) | 3.37699966 |
| 28 | Abnormality of small intestinal villus morphology (HP:0011472) | 3.37699966 |
| 29 | Hemorrhage of the eye (HP:0011885) | 3.36838386 |
| 30 | Short phalanx of the thumb (HP:0009660) | 3.35297741 |
| 31 | Woolly hair (HP:0002224) | 3.34198639 |
| 32 | Malnutrition (HP:0004395) | 3.27944514 |
| 33 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 3.26946553 |
| 34 | Hyperkalemia (HP:0002153) | 3.25247669 |
| 35 | Palpitations (HP:0001962) | 3.25131547 |
| 36 | Abnormality of renin-angiotensin system (HP:0000847) | 3.16365699 |
| 37 | Biliary tract neoplasm (HP:0100574) | 3.12370278 |
| 38 | Visceral angiomatosis (HP:0100761) | 3.08672373 |
| 39 | Ventricular fibrillation (HP:0001663) | 3.08128322 |
| 40 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.07436870 |
| 41 | Abnormal foot bone ossification (HP:0010675) | 3.03195492 |
| 42 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.99480646 |
| 43 | Short 1st metacarpal (HP:0010034) | 2.99480646 |
| 44 | Abnormality of the 2nd finger (HP:0004100) | 2.96450918 |
| 45 | Adrenal overactivity (HP:0002717) | 2.93466656 |
| 46 | Goiter (HP:0000853) | 2.90413163 |
| 47 | Dehydration (HP:0001944) | 2.87151217 |
| 48 | Decreased circulating renin level (HP:0003351) | 2.80853840 |
| 49 | Gastrointestinal dysmotility (HP:0002579) | 2.80055971 |
| 50 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.78866546 |
| 51 | Hemangiomatosis (HP:0007461) | 2.76288924 |
| 52 | Conjugated hyperbilirubinemia (HP:0002908) | 2.75957550 |
| 53 | Hypoplasia of dental enamel (HP:0006297) | 2.69548051 |
| 54 | Breech presentation (HP:0001623) | 2.69425058 |
| 55 | Ventricular tachycardia (HP:0004756) | 2.68260639 |
| 56 | Flattened epiphyses (HP:0003071) | 2.63493524 |
| 57 | Esophageal atresia (HP:0002032) | 2.62687857 |
| 58 | Abnormal ossification of hand bones (HP:0005921) | 2.59294786 |
| 59 | Cupped ribs (HP:0000887) | 2.58856163 |
| 60 | Hoarse voice (HP:0001609) | 2.58482072 |
| 61 | Syncope (HP:0001279) | 2.58418435 |
| 62 | Fragile skin (HP:0001030) | 2.58313500 |
| 63 | Abnormal biliary tract morphology (HP:0012440) | 2.57853670 |
| 64 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.56748436 |
| 65 | Abnormal hand bone ossification (HP:0010660) | 2.56436213 |
| 66 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.56427512 |
| 67 | Curly hair (HP:0002212) | 2.50831156 |
| 68 | Rectal prolapse (HP:0002035) | 2.44725013 |
| 69 | Short middle phalanx of finger (HP:0005819) | 2.42927821 |
| 70 | Abnormality of the gastric mucosa (HP:0004295) | 2.42296777 |
| 71 | Fat malabsorption (HP:0002630) | 2.40051458 |
| 72 | Intrahepatic cholestasis (HP:0001406) | 2.39245030 |
| 73 | Hyperaldosteronism (HP:0000859) | 2.38447386 |
| 74 | Congenital sensorineural hearing impairment (HP:0008527) | 2.37679021 |
| 75 | Short hallux (HP:0010109) | 2.36982151 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.36496965 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.36496965 |
| 78 | Progressive sensorineural hearing impairment (HP:0000408) | 2.35133292 |
| 79 | Chronic diarrhea (HP:0002028) | 2.34249328 |
| 80 | Abnormality of vitamin B metabolism (HP:0004340) | 2.34083693 |
| 81 | Hyperparathyroidism (HP:0000843) | 2.31933792 |
| 82 | Large earlobe (HP:0009748) | 2.30988141 |
| 83 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.30501991 |
| 84 | Esophageal varix (HP:0002040) | 2.28195689 |
| 85 | Petechiae (HP:0000967) | 2.28131283 |
| 86 | Neonatal short-limb short stature (HP:0008921) | 2.27685619 |
| 87 | Hyperammonemia (HP:0001987) | 2.25497266 |
| 88 | Eczematoid dermatitis (HP:0000976) | 2.23590036 |
| 89 | Abnormal cartilage morphology (HP:0002763) | 2.23195585 |
| 90 | Nail dystrophy (HP:0008404) | 2.22879382 |
| 91 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.21242662 |
| 92 | Vertebral hypoplasia (HP:0008417) | 2.18409541 |
| 93 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.18409541 |
| 94 | Systemic lupus erythematosus (HP:0002725) | 2.16824962 |
| 95 | Neoplasm of the small intestine (HP:0100833) | 2.16444262 |
| 96 | Neoplasm of the rectum (HP:0100743) | 2.15805848 |
| 97 | Ventricular arrhythmia (HP:0004308) | 2.15709995 |
| 98 | Spinal cord compression (HP:0002176) | 2.15261651 |
| 99 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.14088091 |
| 100 | Absent phalangeal crease (HP:0006109) | 2.12411154 |
| 101 | Vascular calcification (HP:0004934) | 2.10874570 |
| 102 | Uterine neoplasm (HP:0010784) | 2.09083209 |
| 103 | Irregular epiphyses (HP:0010582) | 2.08903999 |
| 104 | Septate vagina (HP:0001153) | 2.07972905 |
| 105 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.07197146 |
| 106 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.05775770 |
| 107 | Vertebral clefting (HP:0008428) | 2.04824985 |
| 108 | Abnormal hair laboratory examination (HP:0003328) | 2.04533515 |
| 109 | Progressive hearing impairment (HP:0001730) | 2.02758894 |
| 110 | Hypotension (HP:0002615) | 2.00420405 |
| 111 | Abnormality of vitamin metabolism (HP:0100508) | 1.98078213 |
| 112 | Alkalosis (HP:0001948) | 1.96222985 |
| 113 | Amelogenesis imperfecta (HP:0000705) | 1.94446159 |
| 114 | Myopathic facies (HP:0002058) | 1.93560402 |
| 115 | Late onset (HP:0003584) | 1.93374278 |
| 116 | Microretrognathia (HP:0000308) | 1.90856312 |
| 117 | Renal tubular acidosis (HP:0001947) | 1.90597428 |
| 118 | Alopecia of scalp (HP:0002293) | 1.90131427 |
| 119 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.89679672 |
| 120 | Chronic bronchitis (HP:0004469) | 1.89203131 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.88756401 |
| 122 | Abnormality of proline metabolism (HP:0010907) | 1.88756401 |
| 123 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.88712825 |
| 124 | Cardiovascular calcification (HP:0011915) | 1.88538283 |
| 125 | Cerebral hemorrhage (HP:0001342) | 1.87576217 |
| 126 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 1.87116062 |
| 127 | Aplasia/hypoplasia of the femur (HP:0005613) | 1.86438891 |
| 128 | Focal segmental glomerulosclerosis (HP:0000097) | 1.83346796 |
| 129 | Thin bony cortex (HP:0002753) | 1.83294111 |
| 130 | Cerebral palsy (HP:0100021) | 1.81866042 |
| 131 | Abnormal vertebral ossification (HP:0100569) | 1.81186309 |
| 132 | Severe short stature (HP:0003510) | 1.79710719 |
| 133 | Symptomatic seizures (HP:0011145) | 1.74761792 |
| 134 | Renal salt wasting (HP:0000127) | 1.73988692 |
| 135 | Abnormality of magnesium homeostasis (HP:0004921) | 1.71845410 |
| 136 | Growth hormone excess (HP:0000845) | 1.67234460 |
| 137 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.64661192 |
| 138 | Protuberant abdomen (HP:0001538) | 1.64084383 |
| 139 | Cone-rod dystrophy (HP:0000548) | 1.63247977 |
| 140 | Hyperphosphatemia (HP:0002905) | 1.61943068 |
| 141 | Widely patent fontanelles and sutures (HP:0004492) | 1.60360902 |
| 142 | Ankle clonus (HP:0011448) | 1.58764262 |
| 143 | Bone pain (HP:0002653) | 1.58695529 |
| 144 | Bundle branch block (HP:0011710) | 1.56672234 |
| 145 | Confusion (HP:0001289) | 1.53797033 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MST1R | 6.84938522 |
| 2 | ACVR1B | 5.78376726 |
| 3 | MST4 | 4.39161037 |
| 4 | FRK | 4.27410219 |
| 5 | PIK3CA | 4.08840504 |
| 6 | LMTK2 | 3.86326298 |
| 7 | MAP2K2 | 3.74027671 |
| 8 | NME1 | 2.93431340 |
| 9 | EPHA2 | 2.91307592 |
| 10 | RIPK1 | 2.81080879 |
| 11 | TESK1 | 2.78607588 |
| 12 | MET | 2.47715721 |
| 13 | PRKG2 | 2.44552089 |
| 14 | EPHB2 | 2.31394722 |
| 15 | MYLK | 2.03273754 |
| 16 | MAP3K2 | 2.00437013 |
| 17 | KSR2 | 1.92246744 |
| 18 | PTK6 | 1.92077036 |
| 19 | MAP2K1 | 1.67289397 |
| 20 | TAOK3 | 1.65532634 |
| 21 | MAP3K12 | 1.51960485 |
| 22 | LIMK1 | 1.45097517 |
| 23 | STK24 | 1.36670132 |
| 24 | TAOK1 | 1.30906104 |
| 25 | FER | 1.24160063 |
| 26 | PTK2 | 1.22216407 |
| 27 | PAK4 | 1.22054378 |
| 28 | GRK6 | 1.17572794 |
| 29 | MAP3K9 | 1.15803657 |
| 30 | MAP2K6 | 1.11803276 |
| 31 | PDK2 | 1.07944255 |
| 32 | CAMK2D | 1.06041188 |
| 33 | PKN2 | 1.04693262 |
| 34 | RIPK4 | 0.98727868 |
| 35 | PRKCI | 0.98247054 |
| 36 | MAP3K1 | 0.95186783 |
| 37 | MAP3K10 | 0.94320354 |
| 38 | ERN1 | 0.94097218 |
| 39 | EPHA4 | 0.92987575 |
| 40 | STK10 | 0.92593469 |
| 41 | DDR2 | 0.91355442 |
| 42 | EEF2K | 0.90982602 |
| 43 | ABL2 | 0.90830195 |
| 44 | EPHB1 | 0.89609866 |
| 45 | ERBB2 | 0.85543529 |
| 46 | MAP3K8 | 0.82132489 |
| 47 | MATK | 0.81427686 |
| 48 | DMPK | 0.75414884 |
| 49 | PRPF4B | 0.74297293 |
| 50 | MAP3K11 | 0.71798902 |
| 51 | MAP3K7 | 0.67573360 |
| 52 | ERBB4 | 0.66551614 |
| 53 | PAK3 | 0.63624905 |
| 54 | LRRK2 | 0.61875678 |
| 55 | CAMK2B | 0.61623792 |
| 56 | PRKAA2 | 0.60005115 |
| 57 | EPHA3 | 0.59853331 |
| 58 | NUAK1 | 0.59326809 |
| 59 | BMX | 0.58216491 |
| 60 | RPS6KB2 | 0.58134101 |
| 61 | MAP3K13 | 0.55753335 |
| 62 | CAMK2G | 0.54369678 |
| 63 | ICK | 0.54332946 |
| 64 | AURKB | 0.52581347 |
| 65 | MAPK11 | 0.52111820 |
| 66 | ARAF | 0.48163047 |
| 67 | CDK19 | 0.46946303 |
| 68 | TESK2 | 0.44662452 |
| 69 | MAP4K1 | 0.43816278 |
| 70 | PAK1 | 0.43808753 |
| 71 | FGFR3 | 0.42721833 |
| 72 | SRC | 0.41248473 |
| 73 | TNIK | 0.40622115 |
| 74 | STK39 | 0.38098499 |
| 75 | LATS1 | 0.36471758 |
| 76 | SMG1 | 0.34454094 |
| 77 | YES1 | 0.34134745 |
| 78 | TTK | 0.33925448 |
| 79 | TBK1 | 0.33416110 |
| 80 | MAP3K3 | 0.33220725 |
| 81 | RET | 0.33171806 |
| 82 | CSK | 0.33123777 |
| 83 | ZAP70 | 0.32510665 |
| 84 | PDPK1 | 0.32504946 |
| 85 | TRIB3 | 0.32175775 |
| 86 | PRKCA | 0.31399300 |
| 87 | FGFR4 | 0.30973637 |
| 88 | NEK1 | 0.30451413 |
| 89 | MELK | 0.30080601 |
| 90 | MAP3K14 | 0.29803444 |
| 91 | NME2 | 0.29223341 |
| 92 | PRKAA1 | 0.28718154 |
| 93 | BMPR2 | 0.28671125 |
| 94 | BCR | 0.28178245 |
| 95 | KSR1 | 0.28127860 |
| 96 | SIK3 | 0.27945747 |
| 97 | TRPM7 | 0.27943666 |
| 98 | ROCK1 | 0.27066476 |
| 99 | WNK4 | 0.26991959 |
| 100 | MAPKAPK3 | 0.26677111 |
| 101 | JAK2 | 0.25895263 |
| 102 | CDC42BPA | 0.24496662 |
| 103 | PRKCQ | 0.24381581 |
| 104 | TYK2 | 0.23823428 |
| 105 | PIK3CG | 0.23344855 |
| 106 | PIM2 | 0.22837571 |
| 107 | FYN | 0.22067800 |
| 108 | OXSR1 | 0.21888299 |
| 109 | PDK1 | 0.21748559 |
| 110 | DAPK3 | 0.21736767 |
| 111 | PAK2 | 0.21701052 |
| 112 | IRAK1 | 0.21268290 |
| 113 | CASK | 0.19750558 |
| 114 | SCYL2 | 0.19579013 |
| 115 | ALK | 0.18629825 |
| 116 | LYN | 0.17734725 |
| 117 | CSNK1A1 | 0.16940157 |
| 118 | PRKCZ | 0.16754384 |
| 119 | PDGFRA | 0.16719871 |
| 120 | RPS6KA2 | 0.16320074 |
| 121 | MAPKAPK2 | 0.15543978 |
| 122 | GRK1 | 0.15259084 |
| 123 | PRKCD | 0.14766857 |
| 124 | ROCK2 | 0.14714310 |
| 125 | NLK | 0.14624096 |
| 126 | PRKACG | 0.14115908 |
| 127 | CDK6 | 0.13913166 |
| 128 | PBK | 0.13769893 |
| 129 | FGFR1 | 0.13575892 |
| 130 | DAPK1 | 0.12507200 |
| 131 | MINK1 | 0.09162721 |
| 132 | IGF1R | 0.08996957 |
| 133 | PRKCB | 0.08264874 |
| 134 | NEK6 | 0.07242661 |
| 135 | PINK1 | 0.06322270 |
| 136 | MAP3K5 | 0.06150726 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur metabolism_Homo sapiens_hsa00920 | 5.61379607 |
| 2 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 4.89576081 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 3.66583972 |
| 4 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.85565742 |
| 5 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 2.76885941 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.63922611 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.61840531 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.55276982 |
| 9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.40612441 |
| 10 | Bile secretion_Homo sapiens_hsa04976 | 2.08556038 |
| 11 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.82078197 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.79326676 |
| 13 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72839052 |
| 14 | Retinol metabolism_Homo sapiens_hsa00830 | 1.68920754 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68670700 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.57861028 |
| 17 | Galactose metabolism_Homo sapiens_hsa00052 | 1.57168695 |
| 18 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.56895227 |
| 19 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.56074324 |
| 20 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.51731843 |
| 21 | Tight junction_Homo sapiens_hsa04530 | 1.49957547 |
| 22 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.48399885 |
| 23 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.41307533 |
| 24 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.40908071 |
| 25 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39610029 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.35433972 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.35028704 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.32143932 |
| 29 | Salivary secretion_Homo sapiens_hsa04970 | 1.25250507 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.23371250 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.18982822 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17128748 |
| 33 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.16098615 |
| 34 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.11654349 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07380413 |
| 36 | Thyroid cancer_Homo sapiens_hsa05216 | 1.03597882 |
| 37 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03590370 |
| 38 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01476281 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95075510 |
| 40 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.91976325 |
| 41 | Adherens junction_Homo sapiens_hsa04520 | 0.91816995 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.91675459 |
| 43 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.90633811 |
| 44 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.89958904 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.87971273 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86931615 |
| 47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.83785458 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82136951 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 0.82062524 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81871663 |
| 51 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.81273215 |
| 52 | Bladder cancer_Homo sapiens_hsa05219 | 0.80772660 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79231537 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77721034 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.77680767 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.75460244 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.74453355 |
| 58 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74139076 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.70822301 |
| 60 | Amoebiasis_Homo sapiens_hsa05146 | 0.70326334 |
| 61 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68948986 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68263207 |
| 63 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67910929 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66735612 |
| 65 | Asthma_Homo sapiens_hsa05310 | 0.66376799 |
| 66 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.65903625 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.64851099 |
| 68 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.62867314 |
| 69 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.61776181 |
| 70 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.61425726 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.60081691 |
| 72 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.58700812 |
| 73 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.57018958 |
| 74 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.55292628 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.53523964 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.51366134 |
| 77 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51314389 |
| 78 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51272202 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50406181 |
| 80 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50106852 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.49382971 |
| 82 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.49324803 |
| 83 | Peroxisome_Homo sapiens_hsa04146 | 0.48757182 |
| 84 | Carbon metabolism_Homo sapiens_hsa01200 | 0.47478139 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46634091 |
| 86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45781008 |
| 87 | Allograft rejection_Homo sapiens_hsa05330 | 0.44764788 |
| 88 | Influenza A_Homo sapiens_hsa05164 | 0.44741037 |
| 89 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43815746 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.43442841 |
| 91 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.41224575 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.40303429 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.39056134 |
| 94 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.37295100 |
| 95 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37065437 |
| 96 | Leishmaniasis_Homo sapiens_hsa05140 | 0.36488070 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35222527 |
| 98 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35133241 |
| 99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.34948243 |
| 100 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.33725854 |
| 101 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.33689470 |
| 102 | Parkinsons disease_Homo sapiens_hsa05012 | 0.32557288 |
| 103 | Shigellosis_Homo sapiens_hsa05131 | 0.32357426 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.30022073 |
| 105 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29800198 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27408571 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.26887803 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.26063513 |
| 109 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.26005719 |
| 110 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.25234837 |
| 111 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.24995810 |
| 112 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.23254868 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.22833154 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.22338227 |
| 115 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.22247053 |
| 116 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.22019050 |
| 117 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.21799081 |
| 118 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.21761857 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.12864427 |
| 120 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.12235417 |
| 121 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.11183264 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.09546007 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.04740657 |
| 124 | Insulin secretion_Homo sapiens_hsa04911 | 0.02043395 |
| 125 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.01313862 |
| 126 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.01055888 |
| 127 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.00200409 |

